Zydus gets USFDA nod for Sugammadex Injection, 200 mg/2 mL and 500 mg/5 mL single-dose vial EP News Bureau Oct 6, 2023 Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide…
Zydus receives tentative approval from the US FDA for Sugammadex Injection EP News Bureau Sep 16, 2022 Sugammadex is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults…
